Drug
EB DT NK Uc101
EB DT NK Uc101: highest development phase Phase 1, developed by Beijing Biotech. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Beijing Biotech
Trials
| Drug | Phase | Indication |
|---|---|---|
| EB-DT-NK-UC101 NCT07492628 | Phase 1 | Bladder Cancer |
Latest
No recent events.
Follow EB DT NK Uc101 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.